Browse Category

Financial News News 12 January 2026

Palantir stock gets a Citi upgrade — and a Feb. 2 earnings date — why PLTR is moving now

Palantir stock gets a Citi upgrade — and a Feb. 2 earnings date — why PLTR is moving now

New York, Jan 12, 2026, 16:59 EST — After-hours Palantir Technologies (PLTR.O) shares climbed about 1.1% in after-hours trading Monday following a Citi upgrade to “buy.” The data-analytics firm’s price target was raised, with the bank citing stronger demand for AI tools. The stock settled at $179.41, swinging between $174.03 and $182.48 during the session. (Investors.com) The call carries weight as Palantir remains valued for rapid growth despite a strong rally last year, making it vulnerable to minor changes in forecasts. Citi’s Tyler Radke noted the company has “broken” conventional valuation metrics, even with shares trading at a forward price-to-earnings
iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

New York, January 12, 2026, 16:13 EST — After-hours Shares of iRhythm Technologies Inc (IRTC.O) fell 5.6% to $169.30 in late Monday trading following a preliminary business update at the J.P. Morgan Healthcare Conference. The stock fluctuated between $157.34 and $179.82, with roughly 1.35 million shares changing hands. Timing is crucial. JPM week typically pushes companies to reveal their cards sooner, and the market has little patience for results that come off as just “fine” after a solid rally. iRhythm now expects 2025 revenue to top the high end of its previous guidance of $740 million, driven by record unit
Why Pattern Group (PTRN) stock slid nearly 8% — and what investors watch next

Why Pattern Group (PTRN) stock slid nearly 8% — and what investors watch next

New York, Jan 12, 2026, 16:00 EST — After-hours Pattern Group Inc (PTRN.O) shares slipped 7.8% to $13.39 in late Nasdaq action on Monday, fluctuating between $13.20 and $14.58 throughout the session. Trading volume hit roughly 1.4 million shares. Stocks managed to hold their ground. The Nasdaq finished 0.5% higher, while the S&P 500 crept up 0.2%, buoyed by gains in tech and Walmart shares. This came even as investors absorbed news of a U.S. Justice Department criminal inquiry into Federal Reserve Chair Jerome Powell. “The news that Powell is being investigated by the Justice Department … I think the
Dave Inc stock drops nearly 9% as fintech lenders slide; CPI test looms for DAVE

Dave Inc stock drops nearly 9% as fintech lenders slide; CPI test looms for DAVE

New York, Jan 12, 2026, 15:40 ET — Regular session Shares of Dave Inc (DAVE.O) dropped 8.8% to $218.29 in late-afternoon trading Monday, after earlier fluctuating between $212.10 and $247.74. The fintech’s stock had closed Friday at $239.35, with roughly 1.1 million shares changing hands by mid-afternoon, according to market data. The drop came as investors backed away from credit-sensitive stocks following U.S. President Donald Trump’s call for a one-year cap on credit card interest rates at 10%, starting Jan. 20. On the docket for Tuesday is the U.S. consumer price index (CPI), a crucial inflation measure that could shift
Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

NEW YORK, Jan 12, 2026, 15:29 (EST) — Trading in the regular session. Caris Life Sciences shares dropped roughly 8.5% to $26.08 in afternoon trading, after fluctuating between $25.35 and $29.77 earlier today. The update comes amid J.P. Morgan Healthcare Conference week, a time when healthcare firms typically try to recalibrate expectations ahead of earnings season. Investors are focused on whether Caris can maintain its growth pace without relying on one-off factors. Caris faces a tight deadline to control the story. The company is set to present at the conference later Monday, but the stock’s steep drop signals that traders
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

New York, Jan 12, 2026, 15:31 EST — Regular session Shares of HealthEquity dropped roughly 10% in Monday afternoon trading following the benefits administrator’s cautious initial fiscal 2027 outlook. The stock last traded down $9.53 at $84.62, hitting a session low around $84.51. This move is significant since HealthEquity’s longer-term targets often set the valuation benchmark for HSA custodians, whose earnings can fluctuate with interest rates and cash yields. Investors have a tight window to process this: the company is slated to present at the J.P. Morgan Healthcare Conference on Tuesday. Traders are locked in on the 2026 trajectory for
Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

NEW YORK, Jan 12, 2026, 15:19 EST — Regular session Shares of Credo Technology Group Holding Ltd climbed 3.1% to $155.10 in Monday afternoon trading, bouncing between $145.35 and $156.43 earlier. The Nasdaq-listed company, with a market cap near $32.5 billion, trades at a triple-digit trailing price-to-earnings ratio as AI-driven semiconductor enthusiasm pushes valuations higher. Credo’s recent rally is significant given its role in data center infrastructure, where it sells high-speed connectivity equipment built to handle growing data loads while cutting power use. That niche is often viewed by investors as a gauge for how long major cloud and AI
Synchrony Financial stock slides on Trump’s 10% credit-card rate cap pitch — what investors watch next

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap pitch — what investors watch next

New York, Jan 12, 2026, 3:33 PM EST — Regular session Shares of Synchrony Financial dropped sharply on Monday, tumbling 8.2% to $79.76 in afternoon trading. The slide followed President Donald Trump’s push for a one-year cap on credit-card interest rates at 10%, a move investors warn could severely tighten card lending profits. (Reuters) The proposal is significant since interest income drives card issuers’ profits, yet the cap is set well below prevailing rates. The Federal Reserve reported the average credit-card interest rate at 20.97% in November, highlighting just how steep a 10% limit would be. (Reuters) Trump announced the
Nebius stock jumps nearly 10% in regular trading as AI-cloud names catch a bid

Nebius stock jumps nearly 10% in regular trading as AI-cloud names catch a bid

New York, Jan 12, 2026, 15:05 ET — Regular session Nebius Group N.V. shares surged close to 10% Monday afternoon, riding the tailwind from a tech sector rally as investors shifted focus back to AI infrastructure names. This shift is significant since Nebius remains a modest public player in the market for premium graphics chips and data centers—the backbone supporting chatbots and various AI applications. When tech risk appetite rises, stocks like Nebius can experience sharp swings. It comes as investors scramble to figure out who will snag early access to NVIDIA’s upcoming AI hardware—and who can actually convert that
Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

New York, Jan 12, 2026, 15:09 EST — Regular session Shares of Figure Technology Solutions, Inc. dropped steeply on Monday following the release of preliminary Q4 operating data, offering a first glimpse into its loan marketplace and crypto-related offerings. The Nasdaq-listed stock slipped 9.6% to $52.50, hitting a low of $49.10 and peaking near $58.67 earlier in the session. (StockAnalysis) This matters because Figure remains a young public company, trading as if it’s a referendum on two shaky bets: housing credit and tokenization. When a stock swings this dramatically based on operating metrics, it signals the market is fixated on
Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

New York, Jan 12, 2026, 15:08 EST — Regular session Bread Financial Holdings’ shares dropped 10.8% to $71.65 in afternoon trading Monday, hitting a low of $70.06 earlier in the session. The move came after President Donald Trump proposed capping credit card interest rates at 10% for one year, beginning Jan. 20. However, Trump didn’t explain how he would enforce compliance among companies. (Reuters) Why it matters now: Credit cards function as “revolving credit,” letting borrowers carry balances and pay them off gradually. Issuers depend on interest income both to cover defaults and to finance perks. Truist Securities cautioned that
D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

NEW YORK, Jan 12, 2026, 15:07 (ET) — Regular session D.R. Horton’s shares edged up roughly 1% to $158.82 Monday afternoon, even as Keefe Bruyette & Woods lowered its price target on the homebuilder. The firm cut the target to $168 from $175 but kept its market perform rating. (MarketScreener) This move is significant as the sector has been reacting to minor tweaks in rate forecasts and policy talk. Investors are hunting for clues that affordability is improving or that builders might reduce incentives without hurting sales. D.R. Horton faces a key test soon. Investors are gearing up ahead of
1 229 230 231 232 233 749

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop